Sequent Scientific - Quaterly Results

07 Nov 2022 Evaluate
The Revenue for the quarter ended  September 2022 of Rs. 542.31 millions grew by 8.23 % from Rs. 501.05 millions.The Net Loss for the quarter ended September 2022 is Rs. -40.50 millions as compared to Net Profit of Rs. 42.87 millions of corresponding quarter ended September 2021Operating profit Margin for the quarter ended September 2022 slipped to -28.53% as compared to 58.29% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 542.31 501.05 8.23 1190.91 967.62 23.08 2196.26 2654.57 -17.26
Other Income 67.26 104.11 -35.40 126.06 161.74 -22.06 276.43 199.66 38.45
PBIDT -28.53 58.29 -148.94 10.37 74.31 -86.04 268.93 552.56 -51.33
Interest 5.75 2.79 106.09 9.29 4.46 108.30 16.10 26.80 -39.93
PBDT -34.28 55.50 -161.77 1.08 69.85 -98.45 252.83 500.15 -49.45
Depreciation 22.49 25.40 -11.46 46.30 48.48 -4.50 95.93 91.28 5.09
PBT -56.77 30.10 -288.60 -45.22 21.37 -311.61 156.90 408.87 -61.63
TAX -16.27 -12.77 27.41 -13.12 -15.41 -14.86 8.91 87.74 -89.84
Deferred Tax -14.37 6.13 -334.42 -13.32 5.07 -362.72 5.20 26.89 -80.66
PAT -40.50 42.87 -194.47 -32.10 36.78 -187.28 147.99 321.13 -53.92
Equity 498.87 496.74 0.43 498.87 496.74 0.43 496.74 496.74 0.00
PBIDTM(%) -5.26 11.63 -145.22 0.87 7.68 -88.66 12.24 20.82 -41.17

Sequent Scientific Share Price

209.00 -4.60 (-2.15%)
29-Dec-2025 15:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.30
Dr. Reddys Lab 1268.00
Cipla 1493.10
Zydus Lifesciences 904.25
Lupin 2078.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×